Junto Capital Management LP reduced its position in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 15.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,004,688 shares of the medical equipment provider’s stock after selling 528,564 shares during the period. […]